Abstract
Objective:
Nightmares and insomnia in combat-related post-traumatic stress disorder (PTSD) might be resistant to treatment with selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines.
Method:
We describe five case reports of patients suffering from long-lasting and intractable nightmares and insomnia. They were given different psychotropic agents in past few years, with no improvement in their sleep disturbance. Olanzapine was added to the current treatment regimen.
Results:
Both nightmares and insomnia improved rapidly after olanzapine institution in all of five patients. No adverse events of olanzapine were reported.
Conclusion:
Olanzapine augmentation might be useful in alleviating treatment-resistant nightmares and insomnia in patients with combat-related PTSD.
MeSH terms
-
Adult
-
Antipsychotic Agents / administration & dosage*
-
Benzodiazepines
-
Combat Disorders / complications
-
Combat Disorders / drug therapy
-
Dose-Response Relationship, Drug
-
Dreams / drug effects*
-
Drug Administration Schedule
-
Drug Therapy, Combination
-
Female
-
Humans
-
Male
-
Middle Aged
-
Olanzapine
-
Pirenzepine / administration & dosage*
-
Pirenzepine / analogs & derivatives*
-
Selective Serotonin Reuptake Inhibitors / administration & dosage*
-
Sleep Initiation and Maintenance Disorders / drug therapy*
-
Sleep Initiation and Maintenance Disorders / etiology
-
Stress Disorders, Post-Traumatic / complications*
-
Stress Disorders, Post-Traumatic / drug therapy*
-
Stress Disorders, Post-Traumatic / etiology
-
Time Factors
-
Treatment Outcome
-
Warfare
Substances
-
Antipsychotic Agents
-
Serotonin Uptake Inhibitors
-
Benzodiazepines
-
Pirenzepine
-
Olanzapine